Hello and Welcome to Patientsville.com, Your Source for all ELOXATIN information. We are dedicated to provide You with ELOXATIN safety information. Learn about ELOXATIN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ELOXATIN Safety Reports
Total ELOXATIN reports: 98.ELOXATIN FDA safety alerts: No.
Reported deaths: 15 Reported hospitalizations: 52.
Take ELOXATIN Side Effects Survey or Share Your ELOXATIN Story. Read More Here.
Showing 1-75 of 98 Next >
Physician from GERMANY reported ELOXATIN problem on Sept 07, 2006. Male patient, weighting 185.2 lb, was diagnosed with bile duct cancer, hypertension and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, jaundice, malaise. ELOXATIN dosage: unknown. During the same period patient was treated with DOCITON, GEMCITABINE. Patient was hospitalized. Patient recovered.ELOXATIN problem was reported by a Pharmacist from UNITED STATES on Nov 22, 2006. Female patient, 55 years of age, weighting 233.0 lb, was diagnosed with colon cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, hyperhidrosis, nausea, vomiting. ELOXATIN dosage: 180MG Q2WEEKS IV. During the same period patient was treated with AVASTIN, LEUCOVORIN, FLUOROURACIL, ALOXI, DECADRON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ELOXATIN problem on Oct 25, 2006. Male patient, 47 years of age, was diagnosed with colorectal cancer metastatic and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ELOXATIN dosage: 120 MG Q2W. During the same period patient was treated with FLUOROURACIL, CALCIUM FOLINATE, ONDANSETRON, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Health Professional from UNITED STATES on Sept 26, 2006. Female patient was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, chills, pyrexia, vomiting. ELOXATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ELOXATIN problem on Sept 26, 2006. Male patient was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, chills, laryngeal oedema, pyrexia, vomiting. ELOXATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Health Professional from UNITED STATES on Sept 26, 2006. Female patient was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, chills, pyrexia, vomiting. ELOXATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ELOXATIN problem on Dec 05, 2006. Male patient, weighting 213.8 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, international normalised ratio abnormal, loss of consciousness, palpitations, pulmonary embolism, refusal of treatment by patient. ELOXATIN dosage: 190 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Male patient, weighting 196.4 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, atelectasis, lung infiltration, pulmonary embolism, pulmonary infarction. ELOXATIN dosage: 175 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Physician from TUNISIA reported ELOXATIN problem on Oct 26, 2006. Male patient, weighting 183.0 lb, was diagnosed with colorectal cancer recurrent and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, hypotension, paraesthesia, shock. ELOXATIN dosage: 170 MG/2W. During the same period patient was treated with FOLINATE CALCIUM. Patient recovered.
ELOXATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Female patient, weighting 262.4 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, infusion related reaction. ELOXATIN dosage: 16 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ELOXATIN problem on June 28, 2007. Male patient, weighting 171.1 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: rib fracture. ELOXATIN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.
ELOXATIN problem was reported by a Physician from SLOVAKIA (Slovak Republic) on July 09, 2007. Female patient was diagnosed with colorectal cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: agitation, circulatory collapse, depression, suicidal ideation, syncope. ELOXATIN dosage: unknown. Patient recovered.
Physician from UNITED STATES reported ELOXATIN problem on July 06, 2007. Female patient, 59 years of age, was diagnosed with colon cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis. ELOXATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 71 years of age, was diagnosed with bile duct cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke. ELOXATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported ELOXATIN problem on July 31, 2007. Female patient, weighting 190.0 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, blood pressure systolic decreased, headache, hyperhidrosis, muscle spasms, syncope. ELOXATIN dosage: 160 MG. During the same period patient was treated with FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Physician from CANADA on July 27, 2007. Female patient was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, peripheral ischaemia. ELOXATIN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from SLOVAKIA (Slovak Republic) reported ELOXATIN problem on July 27, 2007. Female patient was diagnosed with colorectal cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: agitation, circulatory collapse, depression, suicidal ideation, syncope. ELOXATIN dosage: unknown. Patient recovered.
ELOXATIN problem was reported by a Physician from CANADA on Aug 07, 2007. Male patient, 61 years of age, was diagnosed with colon cancer and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, peripheral ischaemia. ELOXATIN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from reported ELOXATIN problem on June 20, 2007. Male patient, weighting 169.8 lb, was diagnosed with rectal cancer recurrent, ischaemia, hypertension, diabetes mellitus, platelet aggregation inhibition, vomiting and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, laryngeal oedema, rales, tongue oedema. ELOXATIN dosage: unknown. During the same period patient was treated with PRAVASTATIN, VASTAREL, SOPROL, GLUCOPHAGE, ASASANTINE, FOZITEC, PRIMPERAN. Patient recovered.
ELOXATIN problem was reported by a Pharmacist from UNITED STATES on Aug 16, 2007. Male patient, 48 years of age, weighting 290.6 lb, was diagnosed with colorectal cancer metastatic and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, muscle spasms, paraesthesia, throat tightness. ELOXATIN dosage: 610 MG ONCE IV. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported ELOXATIN problem on Aug 20, 2007. Female patient, 81 years of age, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: asthenia, eyelid ptosis, iiird nerve paresis, vision blurred. ELOXATIN dosage: unknown. Patient was hospitalized. Patient recovered.
ELOXATIN problem was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Female patient, 58 years of age, weighting 266.0 lb, was diagnosed with colon cancer metastatic and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, oxygen saturation decreased, pruritus. ELOXATIN dosage: 190 MG EVERY 2 WEEKS IV. Patient recovered.
Health Professional from UNITED STATES reported ELOXATIN problem on Sept 12, 2007. Male patient, weighting 238.1 lb, was diagnosed with hepatic neoplasm malignant and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, fatigue, hyperkalaemia, metabolic acidosis, mucosal inflammation, pancreatitis, urinary tract infection. ELOXATIN dosage: unknown. During the same period patient was treated with THORAZINE, SPIRONOLACTONE, PROCHLORPERAZINE, ZOFRAN, QUESTRAN, PHENERGAN, OPIUM TINCTURE, MEGACE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 98 Next >